hVIVO is the new name for Retroscreen Virology.
We are experts in a field where people lead the way. The demand for new treatments in the drive towards a healthier world is a pressing one. There is a real need to better understand the true causes of debilitating and life threatening conditions and identify the best way to alleviate or cure them. However, the process of bringing new, affordable treatments to market is complex, costly, high risk and long.

Our approach is radically simple. We develop human models of disease that enable organisations to discover better drugs and diagnostics and accelerate new product validation.

Our belief is that real people hold the key to understanding human biology and this radically simple concept is opening up a brave new world of breakthrough science. hVIVO has established itself as the world leader in human challenge models.

London, GB
Size (employees)
255 (est)-19%
hVIVO was founded in 1998 and is headquartered in London, GB
Report incorrect company information

hVIVO Office Locations

hVIVO has an office in London
London, GB (HQ)
New Rd
Show all (1)
Report incorrect company information

hVIVO Financials and Metrics

hVIVO Financials

hVIVO's revenue was reported to be £19.85 m in FY, 2016 which is a 157.2% increase from the previous period.

Revenue (FY, 2016)

19.9 m

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

4.2 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

(10 m)

EBITDA (FY, 2016)

(13.2 m)

EBIT (FY, 2016)

(14.8 m)

Market capitalization (31-Oct-2017)

43 m

Closing share price (31-Oct-2017)


Cash (31-Dec-2016)

2.2 m
hVIVO's current market capitalization is £43 m.
GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016


5.3 m5.7 m6 m4.3 m14.4 m27.5 m18.5 m7.7 m19.9 m

Revenue growth, %


Cost of goods sold

3.7 m4 m4.2 m3.7 m10.7 m19.2 m13 m5.3 m15.6 m

Gross profit

1.5 m1.7 m1.8 m614 k3.7 m8.3 m5.5 m2.5 m4.2 m
GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(520.8 k)(153.1 k)(165.6 k)(663 k)508 k1.5 m(17.9 m)(17.6 m)(10 m)

Cash From Operating Activities

(940.5 k)250 k2.1 m4.6 m(16 m)(9.3 m)(12.1 m)

Cash From Financing Activities

(2.1 k)1.3 m(364 k)700 k14.9 m13.4 m11.1 m

Net Change in Cash

(1.1 m)1.3 m553 k1.1 m(2.6 m)3.3 m(1.8 m)
GBPY, 2016

Financial Leverage

-0.4 x
Show all financial metrics
Report incorrect company information